samedan logo
 
 
spacer
home > ict
PUBLICATIONS

International Clinical Trials

 
International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.

Published quarterly, and edited by Dr Graham Hughes, the journal offers a platform of communication and information-sharing for executive and strategic decision-makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.

Prompted by the synergies between trial operations and wider contract research and outsourcing issues, ICT joined forces with sister title European Pharmaceutical Contractor (EPC) in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.
 
For further information please contact:

Advertising
Nick Matthews   

Editorial
Thanh Thanh Lam

Connect with us on Twitter: follow @IntClinTrials

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


Click here to view the digital version of ICT


 


  Click here to view the digital version of Medical Writing:
The Backbone of Clinical Development
 
 

 

ict
 
 
Featured in this issue
Supply Chain & Manufacturing
Supply Chain Operations

Risky Move


The majority of pharma businesses rely on ICH guidelines to help mitigate risk in their supply chains. However, Mark Sawicki at Cryoport explains why this method needs to be re-evaluated in the wake of the shift from small molecule products to biologics and regenerative therapies.


Introduction
Editor’s Comment

With a wide range of topics from patient recruitment and retention to pharma after Brexit, there is a lot to discover in ICT February. Editor Dr Graham Hughes reflects on the most pressing matters.
  Patient Recruitment and Retention
Patient Recruitment

Human Touch


Clinical staff can aid and influence patient enrolment targets in studies, according to Stewart Rosen and Nicola J Smith of QuintilesIMS. They examine the role of clinical trial educators and how it is set to evolve in the future.

spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November


 

Industry Events

Highly Potent Active Pharmaceutical Ingredients 2017

22-23 May 2017, Copthrone Tara Hotel, Scarsdale Place, Kensington, London, UK

The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs.
More info >>

 
News and Press Releases

Anti-Counterfeiting Pharma Conference: PCI’s Ian Parsonage to Share his Expertise on Serialization

Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) will be sharing its specialist Serialization expertise at the upcoming 3rd Anti-Counterfeiting Pharma conference (London Kensington Forum, March 7-8).
More info >>

air transport logo

 

White Papers

Device Develop for Combo Products

Phillips-Medisize

Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement